1. Home
  2. ENOV vs SPNT Comparison

ENOV vs SPNT Comparison

Compare ENOV & SPNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENOV
  • SPNT
  • Stock Information
  • Founded
  • ENOV 1995
  • SPNT 2011
  • Country
  • ENOV United States
  • SPNT Bermuda
  • Employees
  • ENOV N/A
  • SPNT N/A
  • Industry
  • ENOV Fluid Controls
  • SPNT Property-Casualty Insurers
  • Sector
  • ENOV Industrials
  • SPNT Finance
  • Exchange
  • ENOV Nasdaq
  • SPNT Nasdaq
  • Market Cap
  • ENOV 2.1B
  • SPNT 1.9B
  • IPO Year
  • ENOV 2008
  • SPNT N/A
  • Fundamental
  • Price
  • ENOV $31.56
  • SPNT $19.17
  • Analyst Decision
  • ENOV Strong Buy
  • SPNT Hold
  • Analyst Count
  • ENOV 5
  • SPNT 1
  • Target Price
  • ENOV $58.00
  • SPNT $17.00
  • AVG Volume (30 Days)
  • ENOV 1.1M
  • SPNT 752.9K
  • Earning Date
  • ENOV 05-08-2025
  • SPNT 05-05-2025
  • Dividend Yield
  • ENOV N/A
  • SPNT N/A
  • EPS Growth
  • ENOV N/A
  • SPNT N/A
  • EPS
  • ENOV N/A
  • SPNT 0.96
  • Revenue
  • ENOV $2,150,191,000.00
  • SPNT $2,682,300,000.00
  • Revenue This Year
  • ENOV $8.13
  • SPNT $0.32
  • Revenue Next Year
  • ENOV $6.19
  • SPNT $6.00
  • P/E Ratio
  • ENOV N/A
  • SPNT $20.03
  • Revenue Growth
  • ENOV 18.32
  • SPNT N/A
  • 52 Week Low
  • ENOV $29.32
  • SPNT $11.92
  • 52 Week High
  • ENOV $51.10
  • SPNT $19.87
  • Technical
  • Relative Strength Index (RSI)
  • ENOV 36.65
  • SPNT 61.12
  • Support Level
  • ENOV $30.65
  • SPNT $18.92
  • Resistance Level
  • ENOV $37.85
  • SPNT $19.87
  • Average True Range (ATR)
  • ENOV 1.31
  • SPNT 0.63
  • MACD
  • ENOV -0.32
  • SPNT -0.08
  • Stochastic Oscillator
  • ENOV 12.64
  • SPNT 57.58

About ENOV Enovis Corporation

Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.

About SPNT SiriusPoint Ltd.

SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.

Share on Social Networks: